341 F. Supp. 3d 528
E.D. Pa.2018Background
- Defendant Dawud Bey pleaded guilty (2005) to conspiracy to manufacture and distribute cocaine; sentenced to 10 years prison and five years supervised release (2006). He remains on supervised release.
- Supervised release conditions prohibit committing crimes and unlawful possession/use of controlled substances, except as "prescribed by a physician."
- In 2018 Bey tested positive for marijuana on three occasions and admitted use; he produced a Pennsylvania medical-marijuana recommendation and said his doctor and attorney told him Pennsylvania law permitted medical use.
- The United States moved to modify (not revoke) Bey’s supervised release to impose 30 days home detention; Bey contested and requested a hearing, asserting confusion about state vs. federal law and lack of notice.
- The court found Bey credible about his confusion, emphasized that federal law (the Controlled Substances Act) classifies marijuana as Schedule I and prohibits medical use, and concluded state authorization does not override federal law.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether a federal supervisee may use state-authorized medical marijuana while on supervised release | Bey: his physician prescribed marijuana and the supervised-release exception for physician prescriptions allowed his use | U.S.: CSA classifies marijuana Schedule I; no medical-use exception; federal law preempts state law and violates release conditions | Use/possession of medical marijuana violates federal law and Bey’s supervised-release conditions |
| Whether to immediately modify (impose home detention) or defer modification | Bey: his use was based on professional advice and reasonable confusion; not willful; needs time to obtain non-controlled pain treatment | U.S.: seeks immediate modification to home detention for violation | Court granted modification but deferred its immediate effect for 30 days to allow Bey to stop use and obtain alternative, non-controlled pain management |
| Whether scienter or willfulness is required for violation of release conditions | Bey: lack of willfulness due to confusion and professional advice | U.S.: scienter not required; violation occurred regardless | Court acknowledged lack of prior clear federal guidance and found non-willful confusion persuasive in mitigation; declined immediate revocation |
| Whether federal courts must now put supervisees on clear notice about prohibition despite state medical-marijuana laws | Bey: relied on state law and inconsistent enforcement; lacked clear notice | U.S.: federal supremacy makes prohibition clear | Court held federal law preempts state medical-marijuana schemes and now provides clear notice that supervisees may not use/possess marijuana |
Key Cases Cited
- United States v. Oakland Cannabis Buyers’ Cooperative, 532 U.S. 483 (2001) (CSA contains no medical-necessity exception for marijuana)
- Gonzales v. Raich, 545 U.S. 1 (2005) (Congress validly regulates intrastate noncommercial marijuana under Commerce Clause; marijuana designated contraband)
- United States v. Schostag, 895 F.3d 1025 (8th Cir. 2018) (district court has no discretion to permit medical marijuana use while on supervised release)
- United States v. Harvey, 659 F.3d 1272 (9th Cir. 2011) (use of medical marijuana violates supervised-release condition prohibiting unlawful controlled-substance use)
- United States v. Bagdy, 764 F.3d 287 (3d Cir. 2014) (discussing supervised-release conditions and related issues)